HighTower Advisors, LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$81,000
-68.4%
94,699
-0.3%
0.00%
-100.0%
Q2 2023$256,000
-84.0%
95,001
+10.4%
0.00%
-75.0%
Q1 2023$1,605,000
+16.5%
86,0220.0%0.00%
+33.3%
Q4 2022$1,378,000
+23.0%
86,0220.0%0.00%0.0%
Q3 2022$1,120,000
+23.3%
86,0220.0%0.00%
+50.0%
Q2 2022$908,000
-7.1%
86,022
+5.8%
0.00%0.0%
Q1 2022$977,000
-14.8%
81,3220.0%0.00%
-33.3%
Q4 2021$1,147,000
+38.9%
81,322
+0.6%
0.00%
+50.0%
Q3 2021$826,000
-61.6%
80,822
-0.1%
0.00%
-66.7%
Q2 2021$2,153,000
-19.5%
80,865
+4.9%
0.01%
-25.0%
Q1 2021$2,674,000
+1.3%
77,062
+8.3%
0.01%
-27.3%
Q4 2020$2,640,000
-8.5%
71,142
+1.4%
0.01%
-21.4%
Q3 2020$2,884,000
+10.9%
70,151
+9.4%
0.01%0.0%
Q2 2020$2,600,000
+25.6%
64,151
+7.7%
0.01%
+7.7%
Q1 2020$2,070,000
+15.2%
59,573
+41.6%
0.01%
+18.2%
Q4 2019$1,797,000
+13.4%
42,068
-1.9%
0.01%
+22.2%
Q3 2019$1,584,000
-18.6%
42,865
-0.4%
0.01%
-25.0%
Q2 2019$1,945,000
+39.3%
43,040
+67.5%
0.01%
+33.3%
Q1 2019$1,396,000
+10.1%
25,689
-6.1%
0.01%
-10.0%
Q4 2018$1,268,00027,3650.01%
Other shareholders
FIBROGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders